Shingrix is a non-live and recombinant subunit adjuvanted vaccine, which will be administered intramuscularly in two doses. Shingles is caused by the reactivation of the varicella zoster virus
The post GSK gets Chinese approval for shingles vaccine Shingrix appeared first on Pharmaceutical Business review.
Original Article: GSK gets Chinese approval for shingles vaccine Shingrix